• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Type I IFN induction during influenza infection increases the susceptibility to secondary S. pneumoniae Infection by negative regulation of γδ T cells

tetano

Editor, Senior Moderator
J Virol. 2012 Sep 5. [Epub ahead of print]
Type I IFN induction during influenza infection increases the susceptibility to secondary S. pneumoniae Infection by negative regulation of γδ T cells.
Li W, Moltedo B, Moran TM.
Source

Department of Microbiology and Immunology Institute, Mount Sinai School of Medicine, New York, NY 10029, USA.
Abstract

The majority of deaths following influenza infection result from secondary bacterial superinfection, most commonly caused by Streptococcus pneumoniae. Several models have been proposed to explain how primary respiratory viral infections exacerbate secondary bacterial disease but the mechanistic explanations have been contradictory. In this study mice were infected with S. pneumoniae at different days after primary influenza A/X31 virus infection. Our findings show that the induction of type I IFNs during a primary non-lethal influenza infection is sufficient to promote a deadly S.pneumoniae secondary infection. Moreover, mice deficient in type I interferon receptor (IFNAR KO) effectively cleared the secondary bacterial infection from their lungs, increased the recruitment of neutrophils and demonstrated an enhanced innate expression of IL-17 relative to wild type mice. Lung γδ T cells were responsible for almost all IL-17 production and their function is compromised during secondary S.pneumoniae infection of WT but not IFNAR KO mice. Adoptive transfer of γδ T cells from IFNAR KO mice reduced the susceptibility to secondary S.pneumoniae infection in the lung of WT mice. Altogether, our study highlights the importance of type I interferon as a key master regulator that is exploited by opportunistic pathogens such as S.pneumoniae. Our findings may be utilized to design effective preventive and therapeutic strategies that may be beneficial for coinfected patients during influenza epidemics.

PMID:
22951826
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/22951826
 
Back
Top Bottom